Back
WuXi Biologics (Cayman), Inc. 10K Form
Sell
24
WXIBF
WuXi Biologics (Cayman), Inc.
Last Price:
$4.04
Seasonality Move:
-29.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WXIBF News And Ratings
See the #1 stock for the next 7 days that we like better than WXIBF
WXIBF Financial Statistics
Sales & Book Value
| Annual Sales: | $2.6B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 61.33 |
| Annual Sales: | $1.40 |
| Price / Book: | 2.73 |
Profitability
| EPS (TTM): | 0.14260 |
|---|---|
| Net Income (TTM): | $681.6M |
| Gross Margin: | $1.1B |
| Return on Equity: | 7.53% |
| Return on Assets: | 5.95% |
WuXi Biologics (Cayman), Inc. Earnings Forecast
Key WuXi Biologics (Cayman), Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for WXIBF is 40.97%.
-
The Selling, General & Administrative Expenses for WXIBF have been equal to 11.50% of Gross Profit Margin.
-
The Research & Development expenses have been 4.10% of Revenue.
-
The Interest Expense is 3.99% of Operating Income.
-
The Net Earning history of WXIBF is 21.13% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 8 years.
WuXi Biologics (Cayman), Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | WXIBF |
| Website: | wuxibiologics.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 2.73 |
| Quick Ratio: | 1.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 37.06 |
|---|---|
| Forward P/E Ratio: | 0 |
WXIBF Technical Analysis vs Fundamental Analysis
Sell
24
WuXi Biologics (Cayman), Inc. (WXIBF)
is a Sell
Is WuXi Biologics (Cayman), Inc. a Buy or a Sell?
-
WuXi Biologics (Cayman), Inc. stock is rated a SellThe current WuXi Biologics (Cayman), Inc. [WXIBF] share price is $4.04. The Score for WXIBF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.